Treatment For Long-COVID Reaches Crucial Agreement With FDA

Virios Therapeutics Reaches Crucial Agreement with FDA on Long-COVID Treatment Development.

Disclaimer: This article contains affiliate links. If you make a purchase through these links, we may earn a commission at no extra cost to you.

Virios Therapeutics, Inc., a biotechnology company based in Atlanta, Georgia, recently announced that it has reached an important agreement with the U.S. Food and Drug Administration (FDA) regarding the developm…